C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis
Open Access
- 1 November 2021
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 62 (14) , 14
Abstract
Purpose: The purpose of this study was to explore the C-X-C chemokines CXCL2 and CXCL10 as potential anti-inflammatory targets for Bacillus endophthalmitis. Methods: Bacillus endophthalmitis was induced in C57BL/6J, CXCL2−/−, and CXCL10−/− mice. At specific times postinfection, eyes were analyzed for Bacillus, retinal function, and inflammation. The efficacies of intravitreal anti-CXCL2 and anti-CXCL10 with or without gatifloxacin in B. cereus endophthalmitis were also assessed using the same techniques. Results: Despite similar Bacillus growth in eyes of C57BL/6J, CXCL2−/−, and CXCL10−/− mice, retinal function retention was greater in eyes of CXCL2−/− and CXCL10−/− mice compared to that of C57BL/6J mice. Neutrophil migration into eyes of CXCL2−/− and CXCL10−/− mice was reduced to a greater degree compared to that of eyes of C57BL/6J mice. Infected CXCL2−/− and CXCL10−/− mouse eyes had significantly less inflammation compared to that of C57BL/6J eyes. Retinal structures in infected eyes of CXCL2−/− mice were preserved for a longer time than in CXCL10−/− eyes. Compared to untreated eyes, there was less inflammation and significant retention of retinal function in eyes treated with anti-CXCL2 and anti-CXCL10 with or without gatifloxacin. Conclusions: For Bacillus endophthalmitis, the absence of CXCL2 or CXCL10 in mice resulted in retained retinal function and less inflammation. The absence of CXCL2 led to a better clinical outcome than the absence of CXCL10. The use of anti-CXCL2 and anti-CXCL10 limited inflammation during B. cereus endophthalmitis. These results highlight the utility of CXCL2 and CXCL10 as potential targets for anti-inflammatory therapy that can be tested in conjunction with antibiotics for improving treating Bacillus endophthalmitis.Keywords
This publication has 95 references indexed in Scilit:
- Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound HealingAdvances in Wound Care, 2013
- Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral MalariaPLOS ONE, 2013
- Role of Toll-Like Receptor (TLR) 2 in Experimental Bacillus cereus EndophthalmitisPLOS ONE, 2011
- CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implicationsCytokine & Growth Factor Reviews, 2011
- TLR2 Mediates the Innate Response of Retinal Muller Glia to Staphylococcus aureusThe Journal of Immunology, 2011
- Bacillus cereus–Induced Permeability of the Blood–Ocular Barrier during Experimental EndophthalmitisInvestigative Ophthalmology & Visual Science, 2009
- A Role for Tumor Necrosis Factor-α in ExperimentalBacillus cereusEndophthalmitis PathogenesisInvestigative Ophthalmology & Visual Science, 2008
- Toward Improving Therapeutic Regimens forBacillusEndophthalmitisInvestigative Ophthalmology & Visual Science, 2008
- Bacillus cereusInduces Permeability of an In Vitro Blood-Retina BarrierInfection and Immunity, 2008
- Bacterial endophthalmitis: Therapeutic challenges and host–pathogen interactionsProgress in Retinal and Eye Research, 2007